JAMES VARNER: Open Payments
NPI 1497230593 · BEAUFORT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 20 payments from 7 companies in 2025. Trend: 2023 $362 · 2024 $163 · 2025 $411
Food & beverage: $411
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $92 |
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| Corcept Therapeutics | 3 | $74 |
| Lilly USA, LLC | 3 | $60 |
| Dexcom, Inc. | 2 | $50 |
| Abbott Laboratories | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $25 |
Products named: Korlym, MOUNJARO, Rybelsus, Dexcom G6 Transmitter, BREZTRI, Ozempic, FREESTYLE LIBRE 3, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
